<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39205240</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Mechanisms of Gut-Related Viral Persistence in Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1266</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16081266</ELocationID><Abstract><AbstractText>Long COVID (post-acute sequelae of COVID-19-PASC) is a consequence of infection by SARS-CoV-2 that continues to disrupt the well-being of millions of affected individuals for many months beyond their first infection. While the exact mechanisms underlying PASC remain to be defined, hypotheses regarding the pathogenesis of long COVID are varied and include (but are not limited to) dysregulated local or systemic inflammatory responses, autoimmune mechanisms, viral-induced hormonal imbalances, skeletal muscle abnormalities, complement dysregulation, novel abzymes, and long-term persistence of virus and/or fragments of viral RNA or proteins. This review article is based on a comprehensive review of the wide range of symptoms most often observed in long COVID and an attempt to integrate that information into a plausible hypothesis for the pathogenesis of PASC. In particular, it is proposed that long-term dysregulation of the gut in response to viral persistence could lead to the myriad of symptoms observed in PASC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McMillan</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>McMillan Research Ltd., London WC2H 9JQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Anthony J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhal</LastName><ForeName>Bruce D</ForeName><Initials>BD</Initials><Identifier Source="ORCID">0000-0002-5201-432X</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Michigan State University, East Lansing, MI 48824, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">gut</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">viral persistence</Keyword></KeywordList><CoiStatement>Philip McMillan was an employee of McMillan Research Ltd. The other authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>1</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39205240</ArticleId><ArticleId IdType="pmc">PMC11360392</ArticleId><ArticleId IdType="doi">10.3390/v16081266</ArticleId><ArticleId IdType="pii">v16081266</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization COVID-19 Dashboard.  [(accessed on 26 March 2024)].  Available online:  https://data.who.int/dashboards/covid19/cases.</Citation></Reference><Reference><Citation>Frontera J.A., Guekht A., Allegri R.F., Ashraf M., Baykan B., Crivelli L., Easton A., Garcia-Azorin D., Helbok R., Joshi J., et al. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition. J. Neurol. Sci. 2023;454:120827. doi: 10.1016/j.jns.2023.120827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2023.120827</ArticleId><ArticleId IdType="pubmed">37856998</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L., Mauro M., Sansone D., Tassinari A., Gobba F.M., Modenese A., Casolari L., Liviero F., Pavanello S., Scapellato M.L., et al. A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity&#x2014;ORCHESTRA Project. Vaccines. 2023;11:1769. doi: 10.3390/vaccines11121769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11121769</ArticleId><ArticleId IdType="pmc">PMC10747427</ArticleId><ArticleId IdType="pubmed">38140174</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D., Crawley E., Hautvast J., Katz B.Z., Knoop H., Little P., Taylor R., et al. Long COVID and Post-infective Fatigue Syndrome: A Review. Open Forum Infect. Dis. 2021;8:ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000;275:33238&#x2013;33243. doi: 10.1074/jbc.M002615200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M002615200</ArticleId><ArticleId IdType="pubmed">10924499</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000;87:e1&#x2013;e9. doi: 10.1161/01.RES.87.5.e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e278. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper N.M., Lambert D.W., Turner A.J. Discovery and characterization of ACE2&#x2014;A 20-year journey of surprises from vasopeptidase to COVID-19. Clin. Sci. 2020;134:2489&#x2013;2501. doi: 10.1042/CS20200476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200476</ArticleId><ArticleId IdType="pubmed">32990314</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens B.R., Ellory J.C., Preston R.L. B0AT1 Amino Acid Transporter Complexed With SARS-CoV-2 Receptor ACE2 Forms a Heterodimer Functional Unit: In Situ Conformation Using Radiation Inactivation Analysis. Function. 2021;2:zqab027. doi: 10.1093/function/zqab027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/function/zqab027</ArticleId><ArticleId IdType="pmc">PMC8194517</ArticleId><ArticleId IdType="pubmed">34847569</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan P., Dexhiemer T., Neubig R.R., Uhal B.D. COVID-19&#x2014;A Theory of Autoimmunity Against ACE-2 Explained. Front. Immunol. 2021;12:582166. doi: 10.3389/fimmu.2021.582166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.582166</ArticleId><ArticleId IdType="pmc">PMC8021777</ArticleId><ArticleId IdType="pubmed">33833750</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan P., Uhal B.D. COVID-19-A theory of autoimmunity to ACE-2. MOJ Immunol. 2020;7:17&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7351250</ArticleId><ArticleId IdType="pubmed">32656314</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Okuda K., Edwards C.E., Martinez D.R., Asakura T., Dinnon K.H., 3rd, Kato T., Lee R.E., Yount B.L., Mascenik T.M., et al. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell. 2020;182:429&#x2013;446.e14. doi: 10.1016/j.cell.2020.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.042</ArticleId><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Lazartigues E. Angiotensin-converting enzyme 2 in the brain: Properties and future directions. J. Neurochem. 2008;107:1482&#x2013;1494. doi: 10.1111/j.1471-4159.2008.05723.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05723.x</ArticleId><ArticleId IdType="pmc">PMC2667944</ArticleId><ArticleId IdType="pubmed">19014390</ArticleId></ArticleIdList></Reference><Reference><Citation>Udomsinprasert W., Nontawong N., Saengsiwaritt W., Panthan B., Jiaranai P., Thongchompoo N., Santon S., Runcharoen C., Sensorn I., Jittikoon J., et al. Host genetic polymorphisms involved in long-term symptoms of COVID-19. Emerg. Microbes Infect. 2023;12:2239952. doi: 10.1080/22221751.2023.2239952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2239952</ArticleId><ArticleId IdType="pmc">PMC10392286</ArticleId><ArticleId IdType="pubmed">37497655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryche B., St Albin A., Murri S., Lac&#xf4;te S., Pulido C., Ar Gouilh M., Lesellier S., Servat A., Wasniewski M., Picard-Meyer E., et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav. Immun. 2020;89:579&#x2013;586. doi: 10.1016/j.bbi.2020.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7332942</ArticleId><ArticleId IdType="pubmed">32629042</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Cao Z., Xie X., Zhang X., Chen J.Y.-C., Wang H., Menachery V.D., Rajsbaum R., Shi P.-Y. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020;33:108234. doi: 10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalskov L., M&#xf8;hlenberg M., Thyrsted J., Blay-Cadanet J., Poulsen E.T., Folkersen B.H., Skaarup S.H., Olagnier D., Reinert L., Enghild J.J., et al. SARS-CoV-2 evades immune detection in alveolar macrophages. EMBO Rep. 2020;21:e51252. doi: 10.15252/embr.202051252.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202051252</ArticleId><ArticleId IdType="pmc">PMC7645910</ArticleId><ArticleId IdType="pubmed">33112036</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Han K., Blair R., Kenst K., Qin Z., Upcin B., W&#xf6;rsd&#xf6;rfer P., Midkiff C.C., Mudd J., Belyaeva E., et al. SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro. Front. Cell. Infect. Microbiol. 2021;11:701278. doi: 10.3389/fcimb.2021.701278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.701278</ArticleId><ArticleId IdType="pmc">PMC8292147</ArticleId><ArticleId IdType="pubmed">34307198</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura I.B., Buckley A.M., Wilcox M.H. Can SARS-CoV-2 be transmitted via faeces? Curr. Opin. Gastroenterol. 2022;38:26&#x2013;29. doi: 10.1097/MOG.0000000000000794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0000000000000794</ArticleId><ArticleId IdType="pmc">PMC8654121</ArticleId><ArticleId IdType="pubmed">34628417</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatori S., Baldassarre F., Mossa M., Monteleone G. Long COVID in Inflammatory Bowel Diseases. J. Clin. Med. 2021;10:5575. doi: 10.3390/jcm10235575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10235575</ArticleId><ArticleId IdType="pmc">PMC8658587</ArticleId><ArticleId IdType="pubmed">34884276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163:495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Snoeck V., Goddeeris B., Cox E. The role of enterocytes in the intestinal barrier function and antigen uptake. Microbes Infect. 2005;7:997&#x2013;1004. doi: 10.1016/j.micinf.2005.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2005.04.003</ArticleId><ArticleId IdType="pubmed">15925533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbe F., Legraverend C., Jay P. The intestinal epithelium tuft cells: Specification and function. Cell. Mol. Life Sci. 2012;69:2907&#x2013;2917. doi: 10.1007/s00018-012-0984-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-0984-7</ArticleId><ArticleId IdType="pmc">PMC3417095</ArticleId><ArticleId IdType="pubmed">22527717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno H., Kanaya T., Williams I.R. M cell differentiation: Distinct lineage or phenotypic transition? Salmonella provides answers. Cell Host Microbe. 2012;12:607&#x2013;609. doi: 10.1016/j.chom.2012.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.11.003</ArticleId><ArticleId IdType="pubmed">23159049</ArticleId></ArticleIdList></Reference><Reference><Citation>Neutra M.R.V. Role of M cells in transepithelial transport of antigens and pathogens to the mucosal immune system. Am. J. Physiol. Liver Physiol. 1998;274:G785&#x2013;G791. doi: 10.1152/ajpgi.1998.274.5.G785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.1998.274.5.G785</ArticleId><ArticleId IdType="pubmed">9612256</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller H. Intestinal M cells: The fallible sentinels? World J. Gastroenterol. 2007;13:1477&#x2013;1486. doi: 10.3748/wjg.v13.i10.1477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v13.i10.1477</ArticleId><ArticleId IdType="pmc">PMC1876659</ArticleId><ArticleId IdType="pubmed">17461437</ArticleId></ArticleIdList></Reference><Reference><Citation>Neutra M.R., Mantis N.J., Kraehenbuhl J.-P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2001;2:1004&#x2013;1009. doi: 10.1038/ni1101-1004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1101-1004</ArticleId><ArticleId IdType="pubmed">11685223</ArticleId></ArticleIdList></Reference><Reference><Citation>Lueschow S.R., McElroy S.J. The Paneth Cell: The Curator and Defender of the Immature Small Intestine. Front. Immunol. 2020;11:587. doi: 10.3389/fimmu.2020.00587.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00587</ArticleId><ArticleId IdType="pmc">PMC7145889</ArticleId><ArticleId IdType="pubmed">32308658</ArticleId></ArticleIdList></Reference><Reference><Citation>Clevers H.C., Bevins C.L. Paneth cells: Maestros of the small intestinal crypts. Annu. Rev. Physiol. 2013;75:289&#x2013;311. doi: 10.1146/annurev-physiol-030212-183744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-030212-183744</ArticleId><ArticleId IdType="pubmed">23398152</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth S., Franken P., Sacchetti A., Kremer A., Anderson K., Sansom O., Fodde R. Paneth cells in intestinal homeostasis and tissue injury. PLoS ONE. 2012;7:e38965. doi: 10.1371/journal.pone.0038965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0038965</ArticleId><ArticleId IdType="pmc">PMC3380033</ArticleId><ArticleId IdType="pubmed">22745693</ArticleId></ArticleIdList></Reference><Reference><Citation>Suprewicz &#x141;., Swoger M., Gupta S., Piktel E., Byfield F.J., Iwamoto D.V., Germann D., Resze&#x107; J., Marci&#x144;czyk N., Carroll R.J., et al. Extracellular Vimentin as a Target Against SARS-CoV-2 Host Cell Invasion. Small. 2022;18:e2105640. doi: 10.1002/smll.202105640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smll.202105640</ArticleId><ArticleId IdType="pmc">PMC9252327</ArticleId><ArticleId IdType="pubmed">34866333</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R., Xia C., Olejnik J., White M.R., Napoleon M.A., Lotfollahzadeh S., Hauser B.M., Schmidt A.G., Chitalia V., M&#xfc;hlberger E., et al. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells. Proc. Natl. Acad. Sci. USA. 2022;119:e2113874119. doi: 10.1073/pnas.2113874119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113874119</ArticleId><ArticleId IdType="pmc">PMC8833221</ArticleId><ArticleId IdType="pubmed">35078919</ArticleId></ArticleIdList></Reference><Reference><Citation>Diwakarla S., Fothergill L.J., Fakhry J., Callaghan B., Furness J.B. Heterogeneity of enterochromaffin cells within the gastrointestinal tract. Neurogastroenterol. Motil. 2017;29:e13101. doi: 10.1111/nmo.13101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.13101</ArticleId><ArticleId IdType="pmc">PMC5475263</ArticleId><ArticleId IdType="pubmed">28485065</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm L.K., Nielsen S.S.F., Pahus M.H., Frattari G.S., Olesen R., Andersen R., Monrad I., Andersen A.H.F., Thomsen M.M., Konrad C.V., et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. eBioMedicine. 2021;64:103230. doi: 10.1016/j.ebiom.2021.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.-Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren A., Nyavor Y., Beguelin A., Frame L.A. Dangers of the chronic stress response in the context of the microbiota-gut-immune-brain axis and mental health: A narrative review. Front. Immunol. 2024;15:1365871. doi: 10.3389/fimmu.2024.1365871.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1365871</ArticleId><ArticleId IdType="pmc">PMC11096445</ArticleId><ArticleId IdType="pubmed">38756771</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Gao X., Liang J., Wu Q., Shen L., Zheng Y., Ma Y., Peng Y., He Y., Yin J. Association between gut microbiota dysbiosis and poor functional outcomes in acute ischemic stroke patients with COVID-19 infection. mSystems. 2024;9:e0018524. doi: 10.1128/msystems.00185-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msystems.00185-24</ArticleId><ArticleId IdType="pmc">PMC11237522</ArticleId><ArticleId IdType="pubmed">38700338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalam N., Balasubramaniam V.R.M.T. Crosstalk between COVID-19 and the gut-brain axis: A gut feeling. Postgrad. Med. J. 2024;100:qgae030. doi: 10.1093/postmj/qgae030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/postmj/qgae030</ArticleId><ArticleId IdType="pubmed">38493312</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer A.M., Matos Y.L., Lin H.C., Ryman S.G., Birg A., Quinn D.K., Parada A.N., Vakhtin A.A. Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms. Front. Neurosci. 2023;17:1232480. doi: 10.3389/fnins.2023.1232480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1232480</ArticleId><ArticleId IdType="pmc">PMC10568482</ArticleId><ArticleId IdType="pubmed">37841680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalov&#xe1; L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867.e20. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sabatino A., Giuffrida P., Vanoli A., Luinetti O., Manca R., Biancheri P., Bergamaschi G., Alvisi C., Pasini A., Salvatore C., et al. Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease. Am. J. Gastroenterol. 2014;109:258&#x2013;269. doi: 10.1038/ajg.2013.426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2013.426</ArticleId><ArticleId IdType="pubmed">24394748</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Shao B., Dang Q., Chen Z., Zhou Q., Luo H., Yuan W., Sun Z. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19. Front. Immunol. 2021;12:674074. doi: 10.3389/fimmu.2021.674074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.674074</ArticleId><ArticleId IdType="pmc">PMC8631495</ArticleId><ArticleId IdType="pubmed">34858386</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhan H., Zhang F., Liu Q., Tso E.Y., Lui G.C., Chen N., Li A., Lu W., Chan F.K., et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020;159:1302&#x2013;1310.e5. doi: 10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Christophersen A., Lund E.G., Snir O., Sol&#xe0; E., Kanduri C., Dahal-Koirala S., Z&#xfc;hlke S., Molberg &#xd8;., Utz P.J., Rohani-Pichavant M., et al. Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions. Nat. Med. 2019;25:734&#x2013;737. doi: 10.1038/s41591-019-0403-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0403-9</ArticleId><ArticleId IdType="pmc">PMC6647859</ArticleId><ArticleId IdType="pubmed">30911136</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunetti N.S., Davanzo G.G., de Moraes D., Ferrari A.J., Souza G.F., Muraro S.P., Knittel T.L., O Boldrini V., Monteiro L.B., Virg&#xed;lio-Da-Silva J.V., et al. SARS-CoV-2 uses CD4 to infect T helper lymphocytes. eLife. 2023;12:e84790. doi: 10.7554/eLife.84790.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.84790</ArticleId><ArticleId IdType="pmc">PMC10390044</ArticleId><ArticleId IdType="pubmed">37523305</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakolpour S., Rakhshandehroo T., Wei E.X., Rashidian M. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol. Lett. 2020;225:31&#x2013;32. doi: 10.1016/j.imlet.2020.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2020.06.013</ArticleId><ArticleId IdType="pmc">PMC7305732</ArticleId><ArticleId IdType="pubmed">32569607</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Q., Fan L., Liu W., Li J., Yue J., Wang M., Ke X., Yin Y., Chen Q., Jiang C. Direct Evidence of Active SARS-CoV-2 Replication in the Intestine. Clin. Infect. Dis. 2021;73:361&#x2013;366. doi: 10.1093/cid/ciaa925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa925</ArticleId><ArticleId IdType="pmc">PMC7454471</ArticleId><ArticleId IdType="pubmed">32638022</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrillo M., Brogna C., Cristoni S., Querci M., Piazza O., Eede G.V.D. Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology. F1000Research. 2021;10:370. doi: 10.12688/f1000research.52540.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.52540.1</ArticleId><ArticleId IdType="pmc">PMC8283343</ArticleId><ArticleId IdType="pubmed">34336189</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Zlitni S., Brooks E.F., Vance S.E., Dahlen A., Hedlin H., Park R.M., Han A., Schmidtke D.T., Verma R., et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3:371&#x2013;387.e9. doi: 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilen C.B., Lee S., Hsieh L.L., Orchard R.C., Desai C., Hykes B.L., Jr., McAllaster M.R., Balce D.R., Feehley T., Brestoff J.R., et al. Tropism for tuft cells determines immune promotion of norovirus pathogenesis. Science. 2018;360:204&#x2013;208. doi: 10.1126/science.aar3799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar3799</ArticleId><ArticleId IdType="pmc">PMC6039974</ArticleId><ArticleId IdType="pubmed">29650672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting H.-A., von Moltke J. The Immune Function of Tuft Cells at Gut Mucosal Surfaces and Beyond. J. Immunol. 2019;202:1321&#x2013;1329. doi: 10.4049/jimmunol.1801069.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1801069</ArticleId><ArticleId IdType="pmc">PMC6383804</ArticleId><ArticleId IdType="pubmed">30782851</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O., Halpert G., Schimke L.F., Ostrinski Y., Vojdani A., Baiocchi G.C., Freire P.P., Filgueiras I.S., Zyskind I., Lattin M.T., et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat. Commun. 2022;13:1220. doi: 10.1038/s41467-022-28905-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType="pmc">PMC8907309</ArticleId><ArticleId IdType="pubmed">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C., Mardin C., Lucio M., Wallukat G., Hoffmanns J., Schr&#xf6;der T., Raith F., Rogge L., Heltmann F., Moritz M., et al. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. Int. J. Mol. Sci. 2022;23:7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B., Harrer T., Mardin C., Kruse F., Hoffmanns J., Rogge L., Heltmann F., Moritz M., Szewczykowski C., Schottenhamml J., et al. Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection. Front. Med. 2021;8:754667. doi: 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Hartman T.C.O., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubal A., Nel I., Lotersztajn S., Lehuen A. Mucosal-associated invariant T cells and disease. Nat. Rev. Immunol. 2019;19:643&#x2013;657. doi: 10.1038/s41577-019-0191-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0191-y</ArticleId><ArticleId IdType="pubmed">31308521</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Liang M., Song P., Guan W., Shen X. Mucosal-associated invariant T cells in digestive tract: Local guardians or destroyers? Immunology. 2023;170:167&#x2013;179. doi: 10.1111/imm.13653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13653</ArticleId><ArticleId IdType="pubmed">37132045</ArticleId></ArticleIdList></Reference><Reference><Citation>Howson L.J., Salio M., Cerundolo V. MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases. Front. Immunol. 2015;6:303. doi: 10.3389/fimmu.2015.00303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00303</ArticleId><ArticleId IdType="pmc">PMC4468870</ArticleId><ArticleId IdType="pubmed">26136743</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison D.G., Coffman T.M., Wilcox C.S. Pathophysiology of Hypertension: The Mosaic Theory and Beyond. Circ. Res. 2021;128:847&#x2013;863. doi: 10.1161/CIRCRESAHA.121.318082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318082</ArticleId><ArticleId IdType="pmc">PMC8023760</ArticleId><ArticleId IdType="pubmed">33793328</ArticleId></ArticleIdList></Reference><Reference><Citation>Santin A., Spedicati B., Pecori A., Nardone G.G., Concas M.P., Piatti G., Menini A., Tirelli G., Boscolo-Rizzo P., Girotto G. The Bittersweet Symphony of COVID-19: Associations between TAS1Rs and TAS2R38 Genetic Variations and COVID-19 Symptoms. Life. 2024;14:219. doi: 10.3390/life14020219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life14020219</ArticleId><ArticleId IdType="pmc">PMC10890446</ArticleId><ArticleId IdType="pubmed">38398728</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J.R., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A. Postural orthostatic tachycardia syndrome: Clinical presentation, aetiology and management. J. Intern. Med. 2019;285:352&#x2013;366. doi: 10.1111/joim.12852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12852</ArticleId><ArticleId IdType="pubmed">30372565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston C.K., &#x15a;wi&#x105;tkiewicz I., Taub P.R. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19:1880&#x2013;1889. doi: 10.1016/j.hrthm.2022.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner-Scott J., Levy M., Hawkes C., Yeh A., Giovannoni G. Long COVID or post COVID-19 syndrome. Mult. Scler. Relat. Disord. 2021;55:103268. doi: 10.1016/j.msard.2021.103268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pmc">PMC8447548</ArticleId><ArticleId IdType="pubmed">34601388</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S., Kril I., Nadizhko O., Matsyura O., Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: A pilot observational study. Rheumatol. Int. 2022;42:1523&#x2013;1530. doi: 10.1007/s00296-022-05146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan J.L., Shen Y.-J., Morgan D.R., Thorne L.B., Kenney S.C., Dominguez R.L., Gulley M.L. Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa. Dig. Dis. Sci. 2012;57:1887&#x2013;1898. doi: 10.1007/s10620-012-2116-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-012-2116-5</ArticleId><ArticleId IdType="pmc">PMC3535492</ArticleId><ArticleId IdType="pubmed">22410851</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C., Br&#xfc;ningk S.C., Hoch T., Fan B., Muzio G., Thompson R.C., Ceglarek L., Meledin R., Westermann P., Emmenegger M., et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science. 2024;383:eadg7942. doi: 10.1126/science.adg7942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg7942</ArticleId><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Ward S.E., Townsend L., Karampini E., Elliott S., Conlon N., Dunne J., Kiersey R., Naughton A., Gardiner M., et al. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J. Thromb. Haemost. 2022;20:2429&#x2013;2438. doi: 10.1111/jth.15830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15830</ArticleId><ArticleId IdType="pmc">PMC9349977</ArticleId><ArticleId IdType="pubmed">35875995</ArticleId></ArticleIdList></Reference><Reference><Citation>Motto D.G., Chauhan A.K., Zhu G., Homeister J., Lamb C.B., Desch K.C., Zhang W., Tsai H.-M., Wagner D.D. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J. Clin. Investig. 2005;115:2752&#x2013;2761. doi: 10.1172/JCI26007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI26007</ArticleId><ArticleId IdType="pmc">PMC1240119</ArticleId><ArticleId IdType="pubmed">16200209</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B., Charlton B.T., Goulding R.P., Kerkhoff T.J., Breedveld E.A., Noort W., Offringa C., Bloemers F.W., van Weeghel M., Schomakers B.V., et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat. Commun. 2024;15:17. doi: 10.1038/s41467-023-44432-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Myers R., Mehl F., Murphy L., Brooks B., Wilson J.M., Kadl A., Woodfolk J., Zeichner S.L. ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients. mBio. 2024;15:e0054124. doi: 10.1128/mbio.00541-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00541-24</ArticleId><ArticleId IdType="pmc">PMC11005375</ArticleId><ArticleId IdType="pubmed">38501835</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe0; M., Mercad&#xe9;-Besora N., Kolde R., Trinh N.T.H., Roel E., Burn E., Rathod-Mistry T., Kostka K., Man W.Y., Delmestri A., et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: Staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir. Med. 2024;12:225&#x2013;236. doi: 10.1016/S2213-2600(23)00414-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00414-9</ArticleId><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L., Magnano G., Negro C., Filon F.L., on behalf of the ORCHESTRA Working Group SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020&#x2013;31 January 2023. Viruses. 2023;15:1551. doi: 10.3390/v15071551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15071551</ArticleId><ArticleId IdType="pmc">PMC10384331</ArticleId><ArticleId IdType="pubmed">37515237</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>